MariusNStanMD
Endocrinology • Rochester, MNDiabetes, Lipid Metabolism
Assistant Professor, Internal Medicine, Mayo Medical School
Dr. Stan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Endocrinology, Diabetes, and Metabolism, 2004 - 2007
Danbury HospitalResidency, Internal Medicine, 1996 - 2001
Iuliu Hatieganu University of Medicine and PharmacyClass of 1994
Certifications & Licensure
MN State Medical License 2004 - 2025
WI State Medical License 2003 - 2005
AL State Medical License 2000 - 2003
CT State Medical License 1998 - 2000- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Trial of Rituximab for Graves' Ophthalmopathy Start of enrollment: 2008 Apr 01
- Teriparatide for Postsurgical Hypoparathyroidism Start of enrollment: 2010 Nov 01
- Radiofrequency Ablation for Amiodarone-induced Thyrotoxicosis Start of enrollment: 2018 Nov 19
Publications & Presentations
PubMed
- Epidemiology and Management of Moderate to Severe Thyroid Eye Disease in the United States: Analysis of a Healthcare Claims Database.Marius N Stan, Lilly H Wagner, Kharisa N Rachmasari, Brett Venker, Joel Arackal
Clinical Endocrinology. 2024-12-17 - The Epidemiology of Thyroid Eye Disease in Olmsted County, Minnesota, 2005-2020.Kharisa N Rachmasari, Dana Hamadi, Prabin Thapa, Elizabeth A Bradley, Marius N Stan
Thyroid. 2024-12-01 - PAPP-A as a Potential Target in Thyroid Eye Disease.Cheryl A Conover, Laurie K Bale, Marius N Stan
The Journal of Clinical Endocrinology and Metabolism. 2024-11-18
Authored Content
- Medical Therapy in Patients with Moderate to Severe, Steroid-Resistant, Thyroid Eye DiseaseAugust 2023
Press Mentions
Batoclimab Shows Rapid Effect on Key Graves’ Disease MarkersNovember 4th, 2024- Mayo Clinic Q and a: Understanding Graves’ DiseaseAugust 27th, 2024
- Thyroid Eye Disease Requires Joint Management with OphthalmologistsSeptember 20th, 2021
- Join now to see all
Professional Memberships
- Member
- Member
Other Languages
- Italian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
